1. COVID-19-associated risks and effects in myasthenia gravis (CARE-MG). Issue 12 (December 2020) Authors: Muppidi, Srikanth; Guptill, Jeffrey T; Jacob, Saiju; Li, Yingkai; Farrugia, Maria E; Guidon, Amanda C; Tavee, Jinny O; Kaminski, Henry; Howard, James F; Cutter, Gary; Wiendl, Heinz; Maas, Matthew B; Illa, Isabel; Mantegazza, Renato; Murai, Hiroyuki; Utsugisawa, Kimiaki; Nowak, Richard J; Guidon, ... Journal: Lancet neurology Issue: Volume 19:Issue 12(2020) Page Start: 970 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Distinct representation of muscle weakness in QMG and MG-ADL – Authors' reply. Issue 3 (March 2018) Authors: Howard, James F; O'Brien, Fanny; Wang, Jing-Jing Journal: Lancet neurology Issue: Volume 17:Issue 3(2018) Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America. Issue 9 (18th September 2020) Authors: Green, Joshua D; Barohn, Richard J; Bartoccion, Emanuela; Benatar, Michael; Blackmore, Derrick; Chaudhry, Vinay; Chopra, Manisha; Corse, Andrea; Dimachkie, Mazen M; Evoli, Amelia; Florence, Julaine; Freimer, Miriam; Howard, James F; Jiwa, Theresa; Kaminski, Henry J; Kissel, John T; Koopman, Wilma... Journal: BMJ open Issue: Volume 10:Issue 9(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Neuromuscular junction disorders : diagnosis and treatment /: diagnosis and treatment. (©2004) Other Names: Meriggioli, Matthew N; Howard, James F; Harper, C. Michel Record Type: Book Extent: 1 online resource (xi, 300 pages), illustrations View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Issue 12 (December 2017) Authors: Howard, James F; Utsugisawa, Kimiaki; Benatar, Michael; Murai, Hiroyuki; Barohn, Richard J; Illa, Isabel; Jacob, Saiju; Vissing, John; Burns, Ted M; Kissel, John T; Muppidi, Srikanth; Nowak, Richard J; O'Brien, Fanny; Wang, Jing-Jing; Mantegazza, Renato Journal: Lancet neurology Issue: Volume 16:Issue 12(2017:Dec.) Page Start: 976 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study. Issue 5 (May 2023) Authors: Howard, James F; Bresch, Saskia; Genge, Angela; Hewamadduma, Channa; Hinton, John; Hussain, Yessar; Juntas-Morales, Raul; Kaminski, Henry J; Maniaol, Angelina; Mantegazza, Renato; Masuda, Masayuki; Sivakumar, Kumaraswamy; Śmiłowski, Marek; Utsugisawa, Kimiaki; Vu, Tuan; Weiss, Michael D; Zajda, M... Journal: Lancet neurology Issue: Volume 22:Issue 5(2023) Page Start: 395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Issue 7 (July 2021) Authors: Howard, James F; Bril, Vera; Vu, Tuan; Karam, Chafic; Peric, Stojan; Margania, Temur; Murai, Hiroyuki; Bilinska, Malgorzata; Shakarishvili, Roman; Smilowski, Marek; Guglietta, Antonio; Ulrichts, Peter; Vangeneugden, Tony; Utsugisawa, Kimiaki; Verschuuren, Jan; Mantegazza, Renato; De Bleeker, Jan;... Journal: Lancet neurology Issue: Volume 20:Issue 7(2021) Page Start: 526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Issue 7 (July 2021) Authors: Howard, James F; Bril, Vera; Vu, Tuan; Karam, Chafic; Peric, Stojan; Margania, Temur; Murai, Hiroyuki; Bilinska, Malgorzata; Shakarishvili, Roman; Smilowski, Marek; Guglietta, Antonio; Ulrichts, Peter; Vangeneugden, Tony; Utsugisawa, Kimiaki; Verschuuren, Jan; Mantegazza, Renato; De Bleecker, Jan... Journal: Lancet neurology Issue: Volume 20:Issue 7(2021) Page Start: 526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗